Browse 1 antibody drug conjugate adc patentability cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
CAFC Affirms PTAB Decision, Upholding Seagen's Cancer Drug Patent
Seagen Inc. v. Daiichi Sankyo Company, Ltd., decided by Federal Circuit on December 2, 2025, resulted in a defendant win outcome. The core dispute centered on whether Daiichi Sankyo's patent for a can...
CaseLawBrief currently tracks 1 antibody drug conjugate adc patentability cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 1.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.